Cell-free DNA methylome analysis for early preeclampsia prediction
M De Borre, H Che, Q Yu, L Lannoo, K De Ridder… - Nature Medicine, 2023 - nature.com
Preeclampsia (PE) is a leading cause for peripartal morbidity, especially if developing early
in gestation. To enable prophylaxis in the prevention of PE, pregnancies at risk of PE must …
in gestation. To enable prophylaxis in the prevention of PE, pregnancies at risk of PE must …
Cell-free DNA methylome analysis for early preeclampsia prediction
M De Borre, H Che, Q Yu, L Lannoo, K De Ridder… - 2023 - documentserver.uhasselt.be
Preeclampsia (PE) is a leading cause for peripartal morbidity, especially if developing early
in gestation. To enable prophylaxis in the prevention of PE, pregnancies at risk of PE must …
in gestation. To enable prophylaxis in the prevention of PE, pregnancies at risk of PE must …
Cell-free DNA methylome analysis for early preeclampsia prediction
M De Borre, H Che, Q Yu, L Lannoo… - Nature …, 2023 - pubmed.ncbi.nlm.nih.gov
Preeclampsia (PE) is a leading cause for peripartal morbidity, especially if developing early
in gestation. To enable prophylaxis in the prevention of PE, pregnancies at risk of PE must …
in gestation. To enable prophylaxis in the prevention of PE, pregnancies at risk of PE must …
Cell-free DNA methylome analysis for early preeclampsia prediction.
M De Borre, H Che, Q Yu, L Lannoo, K De Ridder… - Nat Med, 2023 - lirias.kuleuven.be
Preeclampsia (PE) is a leading cause for peripartal morbidity, especially if developing early
in gestation. To enable prophylaxis in the prevention of PE, pregnancies at risk of PE must …
in gestation. To enable prophylaxis in the prevention of PE, pregnancies at risk of PE must …